pilsicainide has been researched along with Left Ventricular Outflow Obstruction in 1 studies
pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pilsicainide (75 mg/day) was administered to reduce the LVOTO." | 1.56 | Development of Pulmonary Edema Despite Negative Fluid Balance with Diuretics in a Patient with Heart Failure and Sigmoid Septum. ( Kamono, M; Komatsu, R; Miyazaki, K; Onuma, Y, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyazaki, K | 1 |
| Onuma, Y | 1 |
| Komatsu, R | 1 |
| Kamono, M | 1 |
1 other study available for pilsicainide and Left Ventricular Outflow Obstruction
| Article | Year |
|---|---|
Development of Pulmonary Edema Despite Negative Fluid Balance with Diuretics in a Patient with Heart Failure and Sigmoid Septum.
Topics: Aged, 80 and over; Diuretics; Furosemide; Heart Failure; Humans; Lidocaine; Male; Pulmonary Edema; V | 2020 |